Caris Life Sciences, Inc. (CAI)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Caris Life Sciences, Inc.’s names, not what it holds today.
2 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Mar 1, 2011 | 7,897,356 | Methods and systems of using exosomes for determining phenotypes | Analysis of biological materials | Caris Life Sciences, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 30, 2016 | 2016/0186266 | MOLECULAR PROFILING FOR PERSONALIZED MEDICINE | Analysis of biological materials | Caris Life Sciences, Inc. |
| Mar 21, 2013 | 2013/0072389 | THERANOSTIC AND DIAGNOSTIC METHODS USING SPARC AND HSP90 | Analysis of biological materials | Caris Life Sciences, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.